Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1986;73:1065-1076

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gallagher, K. P.
Right arrow Articles by Shlafer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gallagher, K. P.
Right arrow Articles by Shlafer, M.

Circulation, Vol 73, 1065-1076, Copyright © 1986 by American Heart Association


ARTICLES

Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion

KP Gallagher, AJ Buda, D Pace, RA Gerren and M Shlafer

Superoxide dismutase (SOD) and catalase (CAT), enzymes that degrade superoxide anion and hydrogen peroxide, respectively, reduce size of infarction in anesthetized, open-chest dogs subjected to coronary occlusion followed by reperfusion. To evaluate potential protective effects of these enzymes in conscious animals, three groups of dogs were instrumented at sterile surgery with a hydraulic occluder on the left circumflex (LCX) coronary artery, sonomicrometers to measure regional wall thickness, and catheters to monitor arterial and left ventricular pressures. Ten to 14 days after surgery, the animals were sedated with morphine sulfate (0.5 mg/kg). The LCX artery was occluded for 3 hr by inflation of the hydraulic cuff. Infusions of SOD (n = 7), CAT (n = 6), or saline (control group, n = 7) were begun 15 min before reperfusion and lasted for 45 min of reperfusion. The doses of SOD and CAT were 5 mg/kg, dissolved in 60 ml of saline, and infused at a rate of 1 ml/min. Myocardial blood flow was measured with tracer-labeled microspheres (15 micron diameter) before occlusion, after 5 to 10 min of occlusion, after 150 min of occlusion, and 5 to 10 min after reperfusion. Size of infarction was measured 24 hr later by dual- perfusion staining with Evans blue and triphenyl tetrazolium. Size of infarction (expressed as a percentage of area at risk) did not differ significantly among the three groups: control, 32 +/- 17% (mean +/- SD); SOD, 38 +/- 17%; CAT, 27 +/- 17%. Hemodynamic parameters and myocardial blood flows (measured before infusion of any agents) were not significantly different among the three groups. Serum SOD levels in SOD-treated dogs were 19 +/- 2 micrograms/ml at the onset of reperfusion and 29 +/- 3 micrograms/ml at the end of the infusion. Blood assays collected after infusion showed a monoexponential decay of SOD levels with a half-life of 22 +/- 6 min. We conclude that myocardial protection by SOD or CAT is model dependent. In conscious dogs subjected to 3 hr of coronary occlusion followed by reperfusion, SOD and CAT failed to alter size of infarction.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
E. Murphy and C. Steenbergen
Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Physiol Rev, April 1, 2008; 88(2): 581 - 609.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Fukushima, S. R. Coppen, A. Varela-Carver, G. Brindley, K. Yamahara, P. Sarathchandra, M. H. Yacoub, and K. Suzuki
Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration
Cardiovasc Res, February 1, 2006; 69(2): 459 - 465.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Jones, M. R. Hoffmeyer, B. R. Sharp, Y.-S. Ho, and D. J. Lefer
Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H277 - H282.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. P. Jones, S. D. Trocha, and D. J. Lefer
Pretreatment With Simvastatin Attenuates Myocardial Dysfunction After Ischemia and Chronic Reperfusion
Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 2059 - 2064.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Ikeda, L. H Young, R. Scalia, C. R Ross, and A. M Lefer
PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion
Cardiovasc Res, January 1, 2001; 49(1): 69 - 77.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. L. Park and B. R. Lucchesi
Mechanisms of myocardial reperfusion injury
Ann. Thorac. Surg., November 1, 1999; 68(5): 1905 - 1912.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Suzuki, Y. Sawa, H. Ichikawa, Y. Kaneda, and H. Matsuda
Myocardial protection with endogenous overexpression of manganese superoxide dismutase
Ann. Thorac. Surg., October 1, 1999; 68(4): 1266 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Wang, H. Chen, H. Qin, S. Sankarapandi, M. W. Becher, P. C. Wong, and J. L. Zweier
Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury
PNAS, April 14, 1998; 95(8): 4556 - 4560.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
G. T. Simonian, H. Dardik, D. Hallac, R. Mazziotta, I. Ibrahim, and R. Stahl
Hemodynamic and Histopathologic Effects of Hydroxyethyl Starch and Superoxide Dismutase Following Splanchnic Arterial Occlusion in a Murine Model
Vascular and Endovascular Surgery, September 1, 1997; 31(5): 645 - 656.
[Abstract] [PDF]


Home page
CirculationHome page
D. Zahger, J. Yano, A. Chaux, M. C. Fishbein, and W. Ganz
Absence of Lethal Reperfusion Injury After 3 Hours of Reperfusion : A Study in a Single-Canine-Heart Model of Ischemia-Reperfusion
Circulation, June 15, 1995; 91(12): 2989 - 2994.
[Abstract] [Full Text]


Home page
Journal of Pharmacy PracticeHome page
R. S. Finley
Overview of Biotechnology in Health Care
Journal of Pharmacy Practice, January 1, 1991; 4(2): 80 - 86.
[PDF]